Safety of Estrogens in Lupus: Hormone Replacement Therapy
Terminated
National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS)
Phase 3
1996-04-01
Safety of Estrogens in Lupus Erythematosus - National Assessment (SELENA) is a study to test
whether postmenopausal women with systemic lupus erythematosus (SLE, or lupus) can safely use
the hormone estrogen. In this part of the study, we will look at the effects of estrogen
replacement therapy on the activity and severity of disease in women with SLE.
Safety of Estrogens in Lupus: Hormone Replacement Therapy
Terminated
Office of Research on Women's Health (ORWH)
Phase 3
1996-04-01
Safety of Estrogens in Lupus Erythematosus - National Assessment (SELENA) is a study to test
whether postmenopausal women with systemic lupus erythematosus (SLE, or lupus) can safely use
the hormone estrogen. In this part of the study, we will look at the effects of estrogen
replacement therapy on the activity and severity of disease in women with SLE.
Safety of Estrogens in Lupus: Hormone Replacement Therapy
Terminated
New York University School of Medicine
Phase 3
1996-04-01
Safety of Estrogens in Lupus Erythematosus - National Assessment (SELENA) is a study to test
whether postmenopausal women with systemic lupus erythematosus (SLE, or lupus) can safely use
the hormone estrogen. In this part of the study, we will look at the effects of estrogen
replacement therapy on the activity and severity of disease in women with SLE.
Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors.
Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data.
The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free.
thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user.
Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.
Alerts Available With Subscription
Alerts are available for users with active subscriptions.
